Janux Therapeutics
Michael Garcia serves as the Director of Accounting at Janux Therapeutics since March 2021, having previously held the position of Assistant Controller. Prior to Janux Therapeutics, Michael Garcia was employed at Synthorx Inc from January 2019 to March 2021 as a Senior Accounting Manager. Earlier in the career, Michael Garcia worked at COI Pharmaceuticals Inc from November 2013 to December 2018 as a Senior Staff Accountant.
Janux Therapeutics
1 followers
Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.